Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results showing up to 40% improvement in early EC using fluorescence molecular aging.
source: GUT BMJ
Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results showing up to 40% improvement in early EC using fluorescence molecular aging.